comparemela.com
Home
Live Updates
Pyramid Biosciences and GeneQuantum Healthcare Announce Preclinical Data for GQ1010, a Potential Best-In-Class TROP2-Targeted Antibody Drug Conjugate, at the 2023 AACR Annual Meeting : comparemela.com
Pyramid Biosciences and GeneQuantum Healthcare Announce Preclinical Data for GQ1010, a Potential Best-In-Class TROP2-Targeted Antibody Drug Conjugate, at the 2023 AACR Annual Meeting
/PRNewswire/ -- Pyramid Biosciences, Inc., a privately-held, clinical-stage biotechnology company focused on developing transformative medicines for patients...
Related Keywords
China
,
Qin Gang
,
Anhui
,
United States
,
American
,
Yajun Sun
,
Laura Dicaprio
,
Brian Lestini
,
Mcdougall Communications
,
Merck Co
,
American Association For Cancer Research
,
Genequantum Healthcare Suzhou Co
,
Prnewswire Pyramid Biosciences Inc
,
Pyramid Biosciences Inc
,
Genequantum Healthcare
,
American Association
,
Cancer Research
,
Annual Meeting
,
Pyramid Biosciences
,
Biosciences Media Inquiries
,
Dougall Communications
,
Nc
,
Health Care Amp Hospitals
,
Medical Pharmaceuticals
,
Biotechnology
,
Clinical Trials Amp Medical Discoveries
,
Trade Show News
,
comparemela.com © 2020. All Rights Reserved.